Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP931386.RAK8VQGXU4xbW3Fr0ee9wL973U2JaeHRwioPA5gM_bC3c130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP931386.RAK8VQGXU4xbW3Fr0ee9wL973U2JaeHRwioPA5gM_bC3c130_assertion type Assertion NP931386.RAK8VQGXU4xbW3Fr0ee9wL973U2JaeHRwioPA5gM_bC3c130_head.
- NP931386.RAK8VQGXU4xbW3Fr0ee9wL973U2JaeHRwioPA5gM_bC3c130_assertion description "[In 1994, the field of bone biology was significantly advanced by the discovery that activating mutations in the fibroblast growth factor receptor 3 (FGFR3) receptor tyrosine kinase (TK) account for the common genetic form of dwarfism in humans, achondroplasia (ACH).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP931386.RAK8VQGXU4xbW3Fr0ee9wL973U2JaeHRwioPA5gM_bC3c130_provenance.
- NP931386.RAK8VQGXU4xbW3Fr0ee9wL973U2JaeHRwioPA5gM_bC3c130_assertion evidence source_evidence_literature NP931386.RAK8VQGXU4xbW3Fr0ee9wL973U2JaeHRwioPA5gM_bC3c130_provenance.
- NP931386.RAK8VQGXU4xbW3Fr0ee9wL973U2JaeHRwioPA5gM_bC3c130_assertion SIO_000772 22045636 NP931386.RAK8VQGXU4xbW3Fr0ee9wL973U2JaeHRwioPA5gM_bC3c130_provenance.
- NP931386.RAK8VQGXU4xbW3Fr0ee9wL973U2JaeHRwioPA5gM_bC3c130_assertion wasDerivedFrom befree-20140225 NP931386.RAK8VQGXU4xbW3Fr0ee9wL973U2JaeHRwioPA5gM_bC3c130_provenance.
- NP931386.RAK8VQGXU4xbW3Fr0ee9wL973U2JaeHRwioPA5gM_bC3c130_assertion wasGeneratedBy ECO_0000203 NP931386.RAK8VQGXU4xbW3Fr0ee9wL973U2JaeHRwioPA5gM_bC3c130_provenance.